Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...
This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...
Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Disc Medicine in a research note ...
Howard Lutnick, the wealthy Wall Street executive whom President Trump has tapped to lead the Department of Commerce, ...
Each year, Cantor Fitzgerald and BGC donate 100 percent of their global ... Mariano Rivera, Willie Randolph, Dwight Doc Gooden, Olympic gold medallist winners Bode Miller and Mikaela Shiffrin and ...
Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Datadog in a research ...
Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...
Cantor Fitzgerald raised the firm’s price target on Tesla (TSLA) to $425 from $365 and keeps a Neutral rating on the shares. Tesla’s adjusted ...
Investment firm Cantor Fitzgerald recently penned a research ... Shares were likely range-bound into DOC/BIS announcement, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback